Affordable Access

Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways.

Authors
  • Toumi, Férial
  • Neunlist, Michel
  • Denis, Marc G
  • Oreshkova, Tsvetelina
  • Laboisse, Christian L
  • Galmiche, Jean-Paul
  • Jarry, Anne
Type
Published Article
Journal
Biochemical and biophysical research communications
Publication Date
Apr 23, 2004
Volume
317
Issue
1
Pages
187–191
Identifiers
PMID: 15047166
Source
Medline
License
Unknown

Abstract

Vasoactive intestinal peptide (VIP) has been shown to be a key regulator of intestinal epithelial functions such as mucus and chloride secretion, paracellular permeability, and cell proliferation. However, its regulatory role in intestinal epithelial chemokine production remains unknown. The aim of this study was (1) to determine whether VIP can modulate intestinal epithelial interleukin-8 (IL-8) production and (2) to identify intracellular mediators responsible for this effect. In the human colonic epithelial cell line HT29-Cl.16E, VIP stimulates IL-8 secretion dose-dependently and IL-8 mRNA level at 10(-9) M. The protein kinase A (PKA) inhibitor PKI did not abolish the effect of VIP. However, inhibition of the ERK1/2 and p38 MAPK pathways reduced the VIP-stimulated IL-8 secretion and mRNA level. Together, our results showed that VIP stimulates IL-8 production in intestinal epithelial cells via PKA-independent and MAPK-dependent pathways. These data suggest that VIPergic pathways can play an immunomodulatory role in intestinal epithelial cells, by regulating epithelial IL-8 secretion.

Report this publication

Statistics

Seen <100 times